[4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors

Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer

(2010) Antonio Garofalo et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment

(2009) Jaume Capdevila et al.   CANCER TREATMENT REVIEWS

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

(2009) Marja Lohela et al.   CURRENT OPINION IN CELL BIOLOGY

Synergistic combinations of signaling pathway inhibitors: Mechanisms for improved cancer therapy

(2009) Paul Dent et al.   DRUG RESISTANCE UPDATES

VEGF receptor protein–tyrosine kinases: Structure and regulation

(2008) Robert Roskoski   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

New developments in multitargeted therapy for patients with solid tumours

(2008) C. Le Tourneau et al.   CANCER TREATMENT REVIEWS

Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells

(2008) Dhara N. Amin et al.   MICROVASCULAR RESEARCH